REFERENCES
- Wise R, Brenwald NP, Gill M, Fraise A. Streptococcus pneumoniae resistance to fluoroquinolones. Lancet 1996; 348: 1660.
- Goldstein FW, Acar JF and the Alexander Project Collaborative Group. Antimicrobial resistance amongst lower respiratory tract isolates of Streptococcus pneumoniae; results of 1992-1993 Western Europe and USA Collaborative surveillance study. J Antimicrob Chemother 1996; 38 ( Suppl A): 71-84.
- Davis R, Bryson HM. Levofloxacin; a review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 1994; 47: 677–700.
- Davis BI, Maese FPV. In vitro susceptibility of Streptococcus pneumoniae isolates to levofloxacin: results from a clinical study. 8th European Congress Clin Microbiol and Infect Dis, Lausanne 25-28 May 1997, Abstract P407.
- Fremaux A, Sissla G, Geslin P. In vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin susceptible and penicillin resistant Streptococcus pneumoniae. 8th Eur. Congress Clin Microbiol and Infect Dis, Lausanne 25-28 May 1997, Abstract P1147.
- Doern GV. Trends in antimicrobial susceptibilities of bacterial pathogens of the respiratory tract. Am J Med 1995; 99, Suppl. 6B: 3-7.
- Goldstein FW, Acar JF, Collaborative group. Antimicrobial resistance amongst lower respiratory tract isolates. J Antimicrob Chemother 1996; 38, Suppl B: 71-84.